HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH

This article was originally published in The Rose Sheet

Executive Summary

Fragrance and cosmetics sales dropped 3.1% to $1.5 mil. for the nine months. Despite the decrease, LVMH had a number of "successful" fragrance launches in September, including Coriolan by Guerlain and the European debut of Christian Dior's Hypnotic Poison and Givenchy's Pi, the Paris-based luxury products group announced Oct. 12. Consolidated sales dropped 8.3% to $1.49 bil. LVMH "continues to expect a drop in profits for 1998 as a whole" due to the deterioration of the worldwide market. However, the firm stated it is "actively pursuing its strategy, focused on growth and creativity in high-potential markets and improving productivity within its various activities"

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel